A rare case of non-traumatic spinal epidural hematoma in lumbar region associated with apixaban therapy.
Petr KrůpaMartin KantaTomas HosszuJiri SoukupPavel RyskaPetr DulicekTomas CesakPublished in: Journal of thrombosis and thrombolysis (2021)
Spontaneous spinal epidural hematoma (SSEH) is a very rare clinical entity with potential diagnostic difficulties and which can result in severe neurological deficit. The etiology of this rare condition is largely not known, but with potential predisposition in patients on anticoagulation medication. This includes the novel anticoagulants with direct inhibition of the factor Xa mechanism (DOACs). These medications are supposed to have more predictable pharmacokinetics with fewer severe haemorrhagic adverse events in comparison with standard warfarin therapy. However, in the last few years, an increasing number of case reports have been published of haemorrhage into the central nervous system. We present a case of non-traumatic spinal epidural hematoma in the lumbar region in a patient on chronic apixaban therapy. To the best of our knowledge, it is the first described SSEH in the lumbar region associated with apixaban therapy.
Keyphrases
- spinal cord
- atrial fibrillation
- venous thromboembolism
- spinal cord injury
- minimally invasive
- healthcare
- rare case
- end stage renal disease
- chronic kidney disease
- stem cells
- direct oral anticoagulants
- ejection fraction
- emergency department
- newly diagnosed
- early onset
- randomized controlled trial
- risk assessment
- human health
- systematic review
- blood brain barrier
- mesenchymal stem cells
- bone marrow
- peritoneal dialysis
- cerebrospinal fluid
- patient reported outcomes
- patient reported
- electronic health record